Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP805018.RA2Xl6or3axrw7Hm33_R8ISNSl3QEPteP9bqz_l9J45as130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP805018.RA2Xl6or3axrw7Hm33_R8ISNSl3QEPteP9bqz_l9J45as130_assertion type Assertion NP805018.RA2Xl6or3axrw7Hm33_R8ISNSl3QEPteP9bqz_l9J45as130_head.
- NP805018.RA2Xl6or3axrw7Hm33_R8ISNSl3QEPteP9bqz_l9J45as130_assertion description "[IL-3 in combination with MIP-1 alpha or receptor activator of nuclear factor-kappa B ligand (RANKL) significantly enhanced human osteoclast (OCL) formation and bone resorption compared with MIP-1 alpha or RANKL alone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805018.RA2Xl6or3axrw7Hm33_R8ISNSl3QEPteP9bqz_l9J45as130_provenance.
- NP805018.RA2Xl6or3axrw7Hm33_R8ISNSl3QEPteP9bqz_l9J45as130_assertion evidence source_evidence_literature NP805018.RA2Xl6or3axrw7Hm33_R8ISNSl3QEPteP9bqz_l9J45as130_provenance.
- NP805018.RA2Xl6or3axrw7Hm33_R8ISNSl3QEPteP9bqz_l9J45as130_assertion SIO_000772 14615378 NP805018.RA2Xl6or3axrw7Hm33_R8ISNSl3QEPteP9bqz_l9J45as130_provenance.
- NP805018.RA2Xl6or3axrw7Hm33_R8ISNSl3QEPteP9bqz_l9J45as130_assertion wasDerivedFrom befree-20140225 NP805018.RA2Xl6or3axrw7Hm33_R8ISNSl3QEPteP9bqz_l9J45as130_provenance.
- NP805018.RA2Xl6or3axrw7Hm33_R8ISNSl3QEPteP9bqz_l9J45as130_assertion wasGeneratedBy ECO_0000203 NP805018.RA2Xl6or3axrw7Hm33_R8ISNSl3QEPteP9bqz_l9J45as130_provenance.